<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Asparagine is_biomarker_for Right-sided colon cancer in women — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>Asparagine</strong>
  <span class="pred">&mdash;is_biomarker_for&rarr;</span>
  <strong>Right-sided colon cancer in women</strong>
</div>
<div class="entity-id">HMDB:HMDB0000168 &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:100%;--color:#2ca02c"></div>
<div class="stat-row">
  <span>Class: Physical (10.0)</span>
  <span>Replicated: 2 papers</span>
  <span>Score: 167.15<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; DB Ref 0.5 &middot; Text Derived 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts &minus;0.5). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 15.85 (Physical, 2 papers)<br>Score from 42 citations: <strong>167.15</strong><br><span style="color:#888">22&times; extends (+110.03) &middot; 13&times; supports (+58.87) &middot; 7&times; contradicts (-1.75)</span><br>Neighbourhood: 171.86</div>


<p class="section-label">EVIDENCE CHAIN &middot; 2 sources</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#2ca02c" title="Physical"></span><span>Physical</span><a href="https://doi.org/10.1038/s41598-020-61851-0">10.1038/s41598-020-61851-0</a> <a href="https://www.ebi.ac.uk/metabolights/MTBLS1122">MTBLS1122</a></div>
<div class="evidence-row"><span class="evidence-dot" style="background:#2ca02c" title="Physical"></span><span>Physical</span><a href="https://doi.org/10.3390/metabo12020164">10.3390/metabo12020164</a> <a href="https://www.ebi.ac.uk/metabolights/MTBLS1122">MTBLS1122</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 42 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:59px"></span><span>13</span><span class="cite-subtotal">&middot; +58.87</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">asparagine synthetase (ASNS) — increases → asparagine</span><span class="cite-claim-weight">+15.85</span><a href="../claim/cbbe665fd9d7a715.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">KPIC2 + XGBoost — distinguishes → liquor types</span><span class="cite-claim-weight">+0.50</span><a href="../claim/0f5b5ba06d9215b4.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">XCMS + XGBoost — distinguishes → liquor types</span><span class="cite-claim-weight">+0.50</span><a href="../claim/57c5d440bdeaac05.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Tryptophan metabolism pathway — predicts → Colorectal Cancer Recurrence</span><span class="cite-claim-weight">+0.01</span><a href="../claim/b5a28b52535da3b5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Purine metabolism pathway — predicts → 5-Year Overall Survival in Colorectal Cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/46632f0d7be0301c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">long-chain and very-long-chain fatty acids — increases → colorectal adenocarcinoma</span><span class="cite-claim-weight">+10.00</span><a href="../claim/cbb3f19d3e71e361.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">de novo lipogenesis — increases → colorectal cancer</span><span class="cite-claim-weight">+10.00</span><a href="../claim/52f46dfa92385363.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">oxidized phospholipids — distinguishes → lymphovascular invasion status in colorectal cancer</span><span class="cite-claim-weight">+10.00</span><a href="../claim/235bd2fc243a7d41.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">oxidized phospholipids — decreases → lymphovascular invasion in colorectal cancer</span><span class="cite-claim-weight">+10.00</span><a href="../claim/5b8f3f1ed7054976.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">bile acids — increases → right-sided colon cancer liver metastasis</span><span class="cite-claim-weight">+0.50</span><a href="../claim/d3c6aea5531a14bf.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Homovanillic acid — is_metabolite_of → Dopamine</span><span class="cite-claim-weight">+0.50</span><a href="../claim/9d15c51242cd4d8a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PD-L1 — decreases → Early-onset colorectal cancer tumor tissue</span><span class="cite-claim-weight">+0.50</span><a href="../claim/992b53bb0ac0d604.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phospholipid signaling — increases → Early-onset colorectal cancer tumor tissue</span><span class="cite-claim-weight">+0.50</span><a href="../claim/4c5bc2efcf6318a3.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:32px"></span><span>7</span><span class="cite-subtotal">&middot; -1.75</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">KPIC2 + XGBoost — distinguishes → left-sided colon cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/996ea3d2ff2fcc97.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">XCMS + XGBoost — distinguishes → left-sided colon cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/6f830dd32f1d2c9a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">carnitines — increases → left-sided colon cancer liver metastasis</span><span class="cite-claim-weight">-0.25</span><a href="../claim/f12db685aedc6256.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">carnitines — is_biomarker_for → fatty acid oxidation</span><span class="cite-claim-weight">-0.25</span><a href="../claim/1a181517f8c54d12.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Homovanillic acid — decreases → Early-onset colorectal cancer tumor tissue</span><span class="cite-claim-weight">-0.25</span><a href="../claim/5b9fd8385eebefbc.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">EGFR signaling — increases → Late-onset colorectal cancer tumor tissue</span><span class="cite-claim-weight">-0.25</span><a href="../claim/aa2e129fdb6224e0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Oxidative stress-related genes — increases → Late-onset colorectal cancer tumor tissue</span><span class="cite-claim-weight">-0.25</span><a href="../claim/e4c557304ecfb2da.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:100px"></span><span>22</span><span class="cite-subtotal">&middot; +110.03</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phenylalanine — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+1.20</span><a href="../claim/2b2ddbab069d3634.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Kynurenine — is_biomarker_for → Colorectal cancer stage</span><span class="cite-claim-weight">+1.55</span><a href="../claim/15709a5e8bd22547.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Asparagine — predicts → 5-year Overall Survival in female CRC patients</span><span class="cite-claim-weight">+12.00</span><a href="../claim/2f6b8b95246fd19c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Serine — distinguishes → 5-year Overall Survival by sex in Colorectal Cancer</span><span class="cite-claim-weight">+19.02</span><a href="../claim/4421b19a889d7968.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Asparagine — correlates_with → Poor prognosis in female Colorectal Cancer patients</span><span class="cite-claim-weight">+12.00</span><a href="../claim/c6bfb7fbe92da16b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Lysophospholipids — predicts → Poor prognosis in female Colorectal Cancer patients</span><span class="cite-claim-weight">+12.00</span><a href="../claim/b50eeb9d6580aa37.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Polyamines — predicts → Poor prognosis in female Colorectal Cancer patients</span><span class="cite-claim-weight">+12.00</span><a href="../claim/6dc001440b4efbb6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Phenylalanine metabolism pathway — predicts → Colorectal Cancer Recurrence</span><span class="cite-claim-weight">+0.01</span><a href="../claim/e9fd48260d547a3d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Indole-3-acetic acid — is_biomarker_for → Colorectal Cancer Recurrence</span><span class="cite-claim-weight">+0.01</span><a href="../claim/6511d3c11340ec71.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Tryptophan — correlates_with → 5-Year Overall Survival in Colorectal Cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/8524ac2670b1fc08.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">SNP in IDO1 gene — predicts → Colorectal Cancer Recurrence</span><span class="cite-claim-weight">+0.01</span><a href="../claim/3c532898e577f272.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Metabolomic pathway activity score — distinguishes → Colorectal Cancer Recurrence vs. Non-Recurrence</span><span class="cite-claim-weight">+0.01</span><a href="../claim/91e61fee63c809b1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">DESI-MSI spectral profiles — distinguishes → colorectal adenocarcinoma</span><span class="cite-claim-weight">+12.00</span><a href="../claim/7fb33aa3d4f25910.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">long-chain and very-long-chain fatty acids — is_biomarker_for → colorectal adenocarcinoma</span><span class="cite-claim-weight">+12.00</span><a href="../claim/e0e672f7538caff6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">oxidized phospholipids — is_biomarker_for → lymphovascular invasion-negative colorectal cancer</span><span class="cite-claim-weight">+12.00</span><a href="../claim/942179be032f2958.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Right-sided colon cancer liver metastasis — predicts → inferior overall survival</span><span class="cite-claim-weight">+0.60</span><a href="../claim/3c80a5d454697be1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">reactive oxygen species-associated metabolites — distinguishes → right-sided colon cancer liver metastasis vs left-sided colon cancer liver metastasis</span><span class="cite-claim-weight">+0.60</span><a href="../claim/1edd9967807dffc0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">MEK-ERK signaling — increases → right-sided colon cancer liver metastasis</span><span class="cite-claim-weight">+0.60</span><a href="../claim/ae985e39be27dde2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PI3K-AKT signaling — increases → right-sided colon cancer liver metastasis</span><span class="cite-claim-weight">+0.60</span><a href="../claim/71c571a33f544ed1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Transforming Growth Factor Beta signaling — increases → right-sided colon cancer liver metastasis</span><span class="cite-claim-weight">+0.60</span><a href="../claim/6da8ef0fd47f1ee0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Homovanillic acid — distinguishes → Early-onset colorectal cancer vs Late-onset colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/0f531ae42a1d7ef1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Tumor metabolome alterations (155 metabolites) — distinguishes → Colorectal cancer tumor vs normal tissue</span><span class="cite-claim-weight">+0.60</span><a href="../claim/6e9d53e11b9bcf11.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>16c02890060bd0fd</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/HMDB:HMDB0000168">HMDB:HMDB0000168</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
